-
Amgen snaps up Dark Blue for $840M
09 Jan 2026 20:58 GMT
-
Amgen Acquires Dark Blue to Advance Novel AML Treatments
09 Jan 2026 17:37 GMT
… million. The transaction strengthens Amgen’s oncology research pipeline … . Through the acquisition, Amgen gains an investigational small … many patients.
According to Amgen, preclinical data from … .
Following the transaction, Amgen plans to integrate Dark …
-
Amgen acquires UK cancer biotech Dark Blue Therapeutics for $840m
08 Jan 2026 21:39 GMT
… expand its oncology pipeline.
Amgen has expanded its oncology … of Research and Development at Amgen, said: “Acute myeloid … from currently available therapies.
Amgen said this could establish the … now be integrated into Amgen’s existing research organisation, …
-
Biotech Amgen acquires UK-based Dark Blue Therapeutics in $840m deal
08 Jan 2026 14:07 GMT
…
US multinational biotechnology company Amgen has announced the acquisition … part of the acquisition, Amgen will integrate Dark Blue … of research and development at Amgen, said: “Acute myeloid … Blue Therapeutics, added: “Amgen has the expertise, resources …
-
Evotec benefits from Dark Blue acquisition by Amgen
08 Jan 2026 11:37 GMT
… Therapeutics by US biotechnology company Amgen Inc. has produced a German … welcomed the transaction.
“Evotec welcomes Amgen’s acquisition of Dark Blue … we see the acquisition by Amgen as strong confirmation of Dark …
-
Call for Application for 2026 Tsinghua Amgen Scholars Program
08 Jan 2026 10:25 GMT
… ;PRNewswire/ -- The Amgen Scholars Program (ASP) is an … international program funded by the Amgen Foundation with the direction … Canada which can host the Amgen summer program. In Asia … of previous programs with the Amgen Foundation.
For more information, …
-
Amgen buys Dark Blue Therapeutics for up to $840m
08 Jan 2026 01:28 GMT
… Dark Blue Therapeutics, said: “Amgen has the expertise, resources and … we are confident that Amgen will build on our pre … of Research and Development at Amgen, added: “Acute myeloid leukaemia … challenging diagnosis of AML.”
Amgen expects to integrate Dark Blue …
-
<![CDATA[Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million]]>
08 Jan 2026 00:42 GMT
… today’s Pharmaceutical Executive Daily, Amgen announces an $840 million acquisition … cell and gene therapy commercialization.
Amgen has agreed to acquire Dark … -molecule therapies. The acquisition reflects Amgen’s continued focus on external …
-
Amgen swoops on European science in two deals worth $1.46B
08 Jan 2026 00:42 GMT
Amgen Inc. has swooped on two …
-
Notable Wednesday Option Activity: ASTS, STZ, AMGN
07 Jan 2026 21:07 GMT
… highlighted in orange:
And Amgen Inc (Symbol: AMGN) options are showing a … a sizeable 80.2% of AMGN's average daily … 0 million underlying shares of AMGN. Below is a chart … ASTS options, STZ options, or AMGN options, visit StockOptionsChannel.com.
Today …